OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In silico methods and tools for drug discovery
Bilal Shaker, Sajjad Ahmad, Jingyu Lee, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104851-104851
Closed Access | Times Cited: 347

Showing 1-25 of 347 citing articles:

Digital twins for health: a scoping review
Evangelia Katsoulakis, Qi Wang, Huanmei Wu, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 69

A comprehensive evaluation of large Language models on benchmark biomedical text processing tasks
Israt Jahan, Md Tahmid Rahman Laskar, Chun Peng, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108189-108189
Open Access | Times Cited: 23

The role and potential of computer-aided drug discovery strategies in the discovery of novel antimicrobials
Samson O. Oselusi, Phumuzile Dube, Adeshina I. Odugbemi, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107927-107927
Open Access | Times Cited: 15

Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
Asimina Zisi, Jiří Bártek, Mikael S. Lindström
Cancers (2022) Vol. 14, Iss. 9, pp. 2126-2126
Open Access | Times Cited: 52

Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process
Md. Rifat Hasan, Ahad Amer Alsaiari, Burhan Zain Fakhurji, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4169-4169
Open Access | Times Cited: 47

Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs
Eslam B. Elkaeed, Hazem Elkady, Amany Belal, et al.
Processes (2022) Vol. 10, Iss. 3, pp. 530-530
Open Access | Times Cited: 36

Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?
Opeyemi Iwaloye, Paul Olamide Ottu, Femi Olawale, et al.
Informatics in Medicine Unlocked (2023) Vol. 41, pp. 101332-101332
Open Access | Times Cited: 31

Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer
Rubi Roy, Tasnim Ria, Debapriya RoyMahapatra, et al.
ACS Omega (2023) Vol. 8, Iss. 19, pp. 16532-16544
Open Access | Times Cited: 27

The prediction of molecular toxicity based on BiGRU and GraphSAGE
Jianping Liu, Xiujuan Lei, Yuchen Zhang, et al.
Computers in Biology and Medicine (2023) Vol. 153, pp. 106524-106524
Closed Access | Times Cited: 23

Integrated Molecular Modeling and Machine Learning for Drug Design
Song Xia, Eric Chen, Yingkai Zhang
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 21, pp. 7478-7495
Open Access | Times Cited: 23

Synthetic bacteria for the detection and bioremediation of heavy metals
Thi Duc Thai, Wonseop Lim, Dokyun Na
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 22

Comprehensive assessment of nine target prediction web services: which should we choose for target fishing?
Kaiyue Ji, Chong Liu, Zhaoqian Liu, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 21

The importance of in-silico studies in drug discovery
Miah Roney, Mohd Fadhlizil Fasihi Mohd Aluwi
Intelligent Pharmacy (2024) Vol. 2, Iss. 4, pp. 578-579
Open Access | Times Cited: 10

The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 10

Investigation of antioxidant and anticancer potential of fucoidan (in-vitro & in-silico) from brown seaweed Padina boergesenii
C. Ragunath, Venkatachalam Ramasubramanian
Algal Research (2024) Vol. 79, pp. 103442-103442
Closed Access | Times Cited: 8

In-silico identification of novel natural drug leads against the Ebola virus VP40 protein: A promising approach for developing new antiviral therapeutics
Noimul Hasan Siddiquee, Md Ifteker Hossain, Md Enamul Kabir Talukder, et al.
Informatics in Medicine Unlocked (2024) Vol. 45, pp. 101458-101458
Open Access | Times Cited: 7

In silico drug design strategies for discovering novel tuberculosis therapeutics
Christian S. Carnero Canales, Aline Renata Pavan, Jean Leandro dos Santos, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 471-491
Closed Access | Times Cited: 7

The latest progress in assay development in leishmaniasis drug discovery: a review of the available papers on PubMed from the past year
G. Santos, Adriano C. Coelho, Juliana Quero Reimão
Expert Opinion on Drug Discovery (2025)
Closed Access

In-silico-based lead optimization of hit compounds targeting mitotic kinesin Eg5 for cancer management
Damilola S. Bodun, Damilola A. Omoboyowa, Victor F. Olofinlade, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access

Improving the binding affinity of plastic degrading cutinase with polyethylene terephthalate (PET) and polyurethane (PU); An In-silico study
Deves Sabari V L, Gokulnath Rajmohan, S B Roshine, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41640-e41640
Open Access

Special Issue “Advances in Drug Discovery and Synthesis”
Lidia Ciccone, Susanna Nencetti
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 584-584
Open Access

Page 1 - Next Page

Scroll to top